Risk of cancer in 767 patients with giant cell arteritis in western Norway: a retrospective cohort with matched controls.
To determine the risk of cancer in a large Norwegian cohort of patients with giant cell arteritis (GCA). This is a hospital-based, retrospective, observational cohort study including patients diagnosed with GCA in Bergen Health Area during 1972-2012. Patients were identified through computerized hospital records using the International Classification of Diseases (ICD)-coding system. Medical records were reviewed. Each patient was randomly assigned population controls matched on age, sex and geography from the Central Population Registry of Norway. Data on the occurrence of cancer was obtained from the Cancer Registry of Norway. The cumulative risk of malignancy was estimated using Kaplan-Meier methods and potential differences were analysed using the Gehan- Breslow- and log rank-tests. We identified 881 cases with a clinical diagnosis of GCA of which 792 fulfilled the American College of Rheumatology (ACR) 1990 classification criteria and 528 were biopsy-verified. Cases with no registered cancer prior to GCA-diagnosis were included in a time-to-event analysis with first cancer as the event (n= 767 with clinical GCA-diagnosis / 686 fulfilling ACR-criteria for GCA / 463 biopsy-verified). These cases were matched with previously cancer-free population controls (n= 1437 / 1284 / 895). We found no significant difference in the risk of malignancy after time of diagnosis/matching for GCA-patients compared to population controls, p-values >0.05. In this study of a large and well-characterized cohort of GCA-patients there was no difference in the risk of malignancy in GCA-patients compared to matched population controls.